Azitra, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AZTR NYSE American 2834 azitrainc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Azitra, Inc.

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock - Jan 15th, 2025 1:30 pm
Azitra Announces Proposed Public Offering of Common Stock - Jan 14th, 2025 9:05 pm
AZTR: Planning 2nd Site for ATR-12 Trial - Nov 15th, 2024 3:14 pm
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates - Nov 12th, 2024 10:05 pm
Azitra to Present at BIO-Europe 2024 - Oct 29th, 2024 1:00 pm
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit - Oct 11th, 2024 1:00 pm
Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress - Sep 24th, 2024 12:00 pm
Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors - Sep 18th, 2024 1:00 pm
Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Sep 6th, 2024 8:30 pm
Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome - Aug 28th, 2024 12:30 pm
AZTR: First ATR-12 Patient Screened - Aug 23rd, 2024 9:40 am
Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors - Aug 22nd, 2024 1:00 pm
Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome - Aug 20th, 2024 8:15 pm
Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates - Aug 12th, 2024 10:23 pm
AZTR: Get Some Skin in the Game - Jul 30th, 2024 9:40 am
CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering - Jul 25th, 2024 9:57 pm
Azitra, Inc. Announces Pricing of $10.0 Million Public Offering - Jul 24th, 2024 1:20 am
Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents - Jul 23rd, 2024 12:00 pm
Azitra, Inc. Announces Reverse Stock Split - Jun 27th, 2024 8:05 pm
AZTR: Historical and Financial Review - Jun 17th, 2024 10:12 am